Severe to Critical COVID 19 With Associated ARDS
1 clinical trials · Condition
◉ Watch Severe to Critical COVID 19 With Associated ARDS
| Record | Firm | Date |
|---|---|---|
| A Phase 2/3 Study to Evaluate FP-025 in Patients With Severe to Critical COVID 19 (NCT04750278) | Foresee Pharmaceuticals Co., Ltd. | 2021-04-06 |
Track Severe to Critical COVID 19 With Associated ARDS automatically
Every clearance here is in the API, with alerts when new ones post.